📢 Update: this account will no longer be active.
Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/
We look forward to staying connected with you there!
The Sonobird trial is active in 40+ sites across Europe and the United States, evaluating whether adding SonoCloud‑guided BBB opening to carboplatin improves survival for patients with first‑recurrence grade glioblastoma.
Learn more about the trial👇
www.sonobird.eu
#glioblastoma #clinicaltrial
Breaking Barriers: How Carthera’s SonoCloud Offers New Perspectives to Brain Cancer Patients 🧠
The American Brain Tumor Association has published an informative article for patients about our SonoCloud technology and how it's being used to treat glioblastoma.
www.abta.org/mindmatters/...
In the meantime, you can learn about our Phase III trial, Sonobird on our dedicated website below👇
www.sonobird.eu
#glioblastoma #clinicaltrial #oncology #neurology #braincancer
🗓️ Meet the Carthera team from next week for the latest insights into our Phase III study evaluating SonoCloud 9 for #glioblastoma
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19 [Booth 9]
💬 Drop by our booths or send us a DM to arrange a meeting
Finding a #braintumor clinical trial can be overwhelming.
That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai
In the meantime, you can learn about our Phase III trial, Sonobird, on our dedicated website below👇
www.sonobird.eu
#glioblastoma #clinicaltrial #oncology #neurology #braincancer
🗓️ Meet the Carthera team in October for the latest insights into our Phase III study evaluating SonoCloud‑9 for #glioblastoma
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19
💬 Drop by our booths or send us a DM to arrange a meeting
GLIOBLASTOMA TRIAL UPDATE 📣
Sonobird is now active in Denmark! 🇩🇰
Two weeks ago, the team at University of Copenhagen included the first Danish patient.
To learn more about the trial including active recruitment centres 👇
sonobird.eu
#Glioblastoma #ClinicalTrial #NeuroOncology
🎙️ Our CSO Michael Canney was recently featured on the Med Tech Gurus podcast, where he dives into how our SonoCloud technology works and its potential to revolutionize glioblastoma care
www.youtube.com/watch?v=3kUF...
#NeuroOncology #ClinicalTrials #Glioblastoma #MedTech
Summer Review: Transforming Glioblastoma Treatment 🧠
🙏 Thank you to our hardworking team, supportive partners, dedicated researchers and brave patients for supporting our mission of providing a new treatment for #glioblastoma
Interviews & Podcast access 👉 linktr.ee/carthera
📣 Our CSO Michael Canney discussed our innovative approach to treating recurrent #glioblastoma on the Brain Wellness podcast. He explains how we use therapeutic ultrasound to enhance chemotherapy delivery to the brain.
www.youtube.com/watch?v=KcUu...
#MedTech #BrainCancer #ClinicalTrials
📣 Our CSO, Michael Canney talks all things Sonobird on the Bindwaves podcast. Learn about SonoCloud-9, our ultrasound implant that disrupts the blood-brain barrier to enhance the delivery of therapeutic drugs.
www.youtube.com/watch?v=B2_D...
#Glioblastoma #BrainCancer #Oncology #ClinicalTrials
This trial involves 40+ clinical sites in the EU & US, evaluating our SonoCloud device to temporarily open the blood-brain barrier and enhance chemotherapy delivery for recurrent #glioblastoma patients
Learn more about the trial and clinical sites in Italy👇
sonobird.eu
#clinicaltrials #medtech
📣 We’re thrilled to announce that our phase 3 trial for recurrent #glioblastoma has launched in Italy with the first patient enrolled in Bologna 🇮🇹
Prof. Giuseppe Lombardi, Italy’s referring investigator and site lead in Padua recently spoke about the trial.
Watch the interview👇
bit.ly/4msq3gX
A new study has identified genes responsible for the spread of #glioblastoma, opening up new avenues for treatment. This breakthrough could pave the way for more effective therapies and improved patient outcomes.
Learn more👇
www.insideprecisionmedicine.com/topics/oncol...
#BrainTumor #Oncology
🧠 Purdue University Researchers Develop a Novel Human Brain Model to Study Alzheimer’s Disease
vet.purdue.edu/news/purdue-...
#Alzheimers
To learn more about our Sonobird trial, visit our dedicated website👇
www.sonobird.eu
#Glioblastoma #ClinicalTrial #Cancer #Oncology #MedTech
🧠 On #GlioblastomaDay, we stand with the global call for better awareness, research & treatments.
Only four FDA-approved drugs & one device exist, we are working to change this through our SonoCloud system.
Read Lynn's story - a patient in our Sonobird trial👇
www.med.unc.edu/neurosurgery...
🔊 New podcast!
Our CSO Dr. Michael Canney joins “Michael and Mom” to talk about the BBB, glioblastoma, and how SonoCloud is changing drug delivery to the brain.
Listen here: www.youtube.com/watch?v=lvRU...
#Glioblastoma #Oncology #ClinicalTrial
Exciting news! Our SonoCloud is among the first devices to receive a positive opinion from the EMA expert panel for Orphan Medical Device status, targeting recurrent glioblastoma. A big step toward CE marking!
ala.associates/regulatory/c...
#Glioblastoma #Oncology #MedTech #NeuroOncology
Our CSO was recently featured on The Childhood Cancer Perspective
Tune in to learn more about our vision and the impactful work being done at Carthera www.youtube.com/watch?v=VsCq...
#BrainCancerResearch #Glioblastoma #MedicalBreakthroughs
Our CSO was recently featured on the PsyDactic podcast!
📲 Want to gain insights into the future of ultrasound technology and the work being done at Carthera?
Listen to the full episode here: psydactic.buzzsprout.com/1909786/epis...
#Ultrasound #Research #Podcast
Le Pr. Olivier Chinot de @aphm-chu-marseille.bsky.social était ce matin sur @bfmmarseille.bsky.social
📽️ Découvrez comment notre technologie innovante est en train de changer la donne dans la lutte contre le cancer du cerveau www.bfmtv.com/marseille/re...
#glioblastome #Santé #RechercheMédicale
Our CSO will be onsite to present a poster about the Sonobird trial for rGBM during the International Society for Therapeutic Ultrasound event in Banff, Alberta, Canada from 21-24 June, 2025!
Find out more about the event and how you can register here👇
istu.org
#ISTU2025 #focusedultrasound
🎧 LISTEN IN: Sound waves meet brain science.
In this podcast, Carthera shares how we use ultrasound to tackle brain tumors and neurodegenerative diseases.
Learn about our SONOBIRD pivotal clinical trial; changing how we fight #glioblastoma 👉 sonobird.eu
podcasts.apple.com/us/podcast/e...
How do we overcome the blood-brain barrier ? 🧠
Despite advancements in #glioblastoma treatment, the BBB remains a critical obstacle.
In this Cureus article, part of Springer Nature, the authors suggest that one of the most promising uses of FUS is BBB disruption.
www.cureus.com/articles/353...
Today, we would like to take the time to thank all the doctors, nurses and patients who have taken part in our clinical trials 👏
Learn more about our SONOBIRD pivotal clinical trial here👇
sonobird.eu
#ClinicalTrialsDay #CTD2025
It's #ClinicalTrialsDay!
Clinical trials are essential to prove the safety and efficacy of our SonoCloud system in order to improve the treatment of brain diseases such as #Glioblastoma and neurodegenerative diseases.
Don't miss this article from NewYork-Presbyterian and @columbiacancer.bsky.social spotlighting our SONOBIRD trial
Huge thanks to Dr. Brian Gill and the team of researchers and clinicians driving this innovation
www.nyp.org/advances/art...
#Glioblastoma #BrainTumor #ClinicalTrials
